Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -16.67% this year. The price of UPB leaped by -38.29% during the last 30 days period. For the last 5-days stocks have slided -15.95%.
52-week price history of UPB Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Upstream Bio Inc’s current trading price is -53.50% away from its 52-week high, while its distance from the 52-week low is -8.48%. The stock’s price range over this timeframe has been between $14.97 and $29.46. The shares of the Healthcare sector company recorded a trading volume of approximately 0.56 million for the day, which was comparatively higher than the average daily volume of 0.39 million over the last three months.
How Moving Averages and Trading Volume Data Work Together
UPB’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for UPB stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
UPB Stock Stochastic Average
The raw stochastic average for Upstream Bio Inc over the last 50 days is presently at 1.75%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 3.13%. Further, the company’s Stochastic %K and %D values for the last 20 days were 11.38% and 13.86%, respectively.
